Hakiri et al. reported the opposite result, where the PD-L1-positive rate was higher in Masaoka–Koga stage III/IV than in Masaoka–Koga stage I/II thymic epithelial tumors (63.6% vs. 21.4%) [40]. The gene discussed is CD274; the disease is thymic epithelial neoplasm.